Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Recurrent Adenosquamous Carcinoma of the Lung After Resection
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s114451
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Informa UK Limited